$80.50 -0.97 (%) Gilead Sciences Inc - NASDAQ

Aug. 24, 2016 | 04:00 PM

Partner Headlines

  1. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily | Aug. 1, 2016 | 15:15PM EST
  2. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 12:13PM EST
  3. Amazon, Alphabet Price Targets Hiked; Ford, Gilead Downgraded

    Investors Business Daily | Jul. 29, 2016 | 09:05AM EST
  4. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily | Jul. 28, 2016 | 10:30AM EST
  5. Stocks Lower As Selling Picks Up Late In Day; Restaurants Tumble

    Investors Business Daily | Jul. 26, 2016 | 13:32PM EST
  6. Gilead Downgraded As Hepatitis C Declines Faster Than Expected

    Investors Business Daily | Jul. 26, 2016 | 09:46AM EST
  7. Gilead, Disney, Yahoo Get Downgrades; Sprint Wins Upgrade

    Investors Business Daily | Jul. 26, 2016 | 09:09AM EST
  8. Gilead Trims Guidance But Beats Q2 Earnings Estimates

    Investors Business Daily | Jul. 25, 2016 | 16:25PM EST
  9. After The Close: Gilead, Las Vegas Sands, Texas Instruments Earnings

    Investors Business Daily | Jul. 25, 2016 | 14:25PM EST
  10. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles

    Investors Business Daily | Jul. 25, 2016 | 05:00AM EST
  11. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 08:00AM EST
  12. Stocks Rally For 4th Week; Dow's Apple, Caterpillar, McDonald's On Tap

    Investors Business Daily | Jul. 22, 2016 | 16:37PM EST
  13. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 13:57PM EST
  14. My Favorite Health Care Stocks

    GuruFocus | Jul. 12, 2016 | 15:26PM EST
  15. The Stocks That Moved The S&P, Dow And Nasdaq Today

    Benzinga | Feb. 17, 2016 | 16:32PM EST
  16. Meet The Stock Mutual Fund That Didn’t Lose Ground In The Week

    IBD | Feb. 16, 2016 | 14:58PM EST
  17. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  18. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  19. Benzinga's Top Initiations

    Benzinga | Feb. 11, 2016 | 09:47AM EST
  20. Zika Virus Spreading: Here's How To Play It Again

    Benzinga | Feb. 10, 2016 | 13:49PM EST
  21. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist

    GuruFocus | Feb. 10, 2016 | 12:13PM EST
  22. Icahn, Gilead, GE Lead Top Insider Trades Of The Week

    Benzinga | Feb. 9, 2016 | 16:07PM EST
  23. Cramer Shares His Thoughts On Chipotle Mexican Grill, Inc. And Gilead Sciences, Inc.

    Benzinga | Feb. 9, 2016 | 07:49AM EST
  24. How To Invest In An Aging World With The 'Live Long & Prosper' ETF

    Benzinga | Feb. 8, 2016 | 10:53AM EST
  25. Bill Gates, Apple Chair, Nike CEO Lead Week’s Insider Trades

    IBD | Feb. 5, 2016 | 13:45PM EST
  26. Strong Dollar Pounds S&P 500 Into Earnings Recession

    IBD | Feb. 5, 2016 | 08:02AM EST
  27. Gilead Sciences Rallies Off Q4 Report

    Benzinga | Feb. 3, 2016 | 15:10PM EST
  28. Zika-Related Social Media Chatter Is Picking Up

    Benzinga | Feb. 3, 2016 | 13:40PM EST
  29. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits High

    IBD | Feb. 3, 2016 | 13:05PM EST
  30. Benzinga's Top Initiations

    Benzinga | Feb. 3, 2016 | 09:45AM EST
  31. Keep an Eye on These 10 Stocks for February 3, 2016

    Benzinga | Feb. 3, 2016 | 04:28AM EST
  32. Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S.

    Benzinga | Feb. 2, 2016 | 17:17PM EST
  33. Earnings Recap For February 2

    Benzinga | Feb. 2, 2016 | 16:45PM EST
  34. Plenty of Opportunity to Buy Individual Stocks: John Buckingham

    GuruFocus | Feb. 2, 2016 | 12:32PM EST
  35. Apple: Think Differently From the Analysts

    GuruFocus | Feb. 1, 2016 | 15:13PM EST
  36. Gilead Hits New 52-Week Low; Here Are Two Reasons Why

    Benzinga | Jan. 29, 2016 | 13:32PM EST
  37. Worst Performing Industries For January 29, 2016

    Benzinga | Jan. 29, 2016 | 12:08PM EST
  38. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  39. Gilead Sciences Now Holds 14.75% of Galapagos Shares

    Benzinga | Jan. 25, 2016 | 04:11AM EST
  40. Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp

    Benzinga | Jan. 24, 2016 | 19:56PM EST
  41. Gilead Sciences Tumbles; Unconfirmed Reports Of Drug Pricing Changes In Japan

    Benzinga | Jan. 20, 2016 | 12:07PM EST
  42. GILEAD SCIENCES

    IBD | Jan. 19, 2016 | 18:48PM EST
  43. The Best Reason to Love Gilead's Market Correction

    GuruFocus | Jan. 18, 2016 | 16:35PM EST
  44. Rethink U.S. Large-Cap Exposure With This ETF

    Benzinga | Jan. 15, 2016 | 13:25PM EST
  45. Amazon Gets New Call; Disney Downgraded Amid Netflix

    IBD | Jan. 15, 2016 | 09:12AM EST
  46. Gurus Are Buying These Stocks Trading Below Peter Lynch value

    GuruFocus | Jan. 14, 2016 | 17:27PM EST
  47. Galapagos, Gilead Cleared FTC to Close Global Partnership on Filgotinib

    Benzinga | Jan. 13, 2016 | 04:20AM EST
  48. Moving To Momentum With ETFs

    Benzinga | Jan. 12, 2016 | 07:28AM EST
  49. Apple Supplier Avago, Guns, Gilead Top Insider Trades

    IBD | Jan. 8, 2016 | 15:10PM EST
  50. Why Gilead Is 'The Apple Of Biotech'

    Benzinga | Jan. 7, 2016 | 16:36PM EST
Trading Center